Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Can Combination Chemotherapy Improve Prognosis of Adrenocortical Cancer? | |
|
| |
Adrenocortical cancer or cancer of the adrenal
glands (glands located just above the kidneys) is a rare type of cancer with
low chances of survival. Data on the usefulness of chemotherapy for this cancer
is limited. Hence, the First International Randomized Trial in Locally Advanced
and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) was planned, which
compared two chemotherapy regimens in advanced adrenocortical cancer. The first regimen included etoposide,
doxorubicin, and cisplatin (EDP) with mitotane for 4-week cycles, while the
second regimen included streptozocin with mitotane for 3-week cycles.
Patients who showed disease progression with a particular regimen were switched
over to the alternative regimen as a second-line treatment.
The study was conducted in 40 specialized centers across 12 countries between June 2004 and October 2009. A total of 304 patients participated in the study.
A positive response to treatment was seen in 23.2% patients in the EDP-mitotane group, which was significantly higher than the number of patients responding to the streptozocin-mitotane regimen i.e. 9.2% patients. In fact, three patients in the EDP-mitotane group showed a complete response to treatment, and 6 patients showed a partial response. These 6 patients later underwent surgery, which made them free of the cancer.
The median duration of progression-free survival was double in the EDP-mitotane group (5 months) as compared to the streptozocin-mitotane group (2.1 months).
However, first-line therapy with EDP-mitotane did not result in a significant improvement in overall survival, as compared with streptozocin-mitotane regimen (14.8 months vs. 12.0 months).
Adverse effects including serious ones were more common with the EDP-mitotane regimen when used as first-line treatment, as compared to the streptozocin-mitotane regimen, though the difference was not statistically significant.
The study thus concludes that a chemotherapy regimen consisting of etoposide, doxorubicin and cisplatin (EDP-mitotane) has better effect on adrenocortical cancer as compared to the streptozocin-mitotane regimen, with a similar incidence of side effects. However, the regimen failed to produce a significant improvement in overall survival; hence newer therapies should be investigated to improve the prognosis of patients suffering from adrenocortical cancer.
Reference:
Combination Chemotherapy in Advanced Adrenocortical Carcinoma; Martin Fassnacht et al; N Engl J Med 2012; 366:2189-2197
Source-Medindia
| |
|
|
More News on: Chronic Lymphocytic Leukemia, Hodgkins Lymphoma, Non-Hodgkins Lymphoma, Chemotherapy, Chemotherapy Drugs, Peritoneal Cancer, Rhabdomyosarcoma, Male Breast Cancer
 Comment & Contribute
|
Related Links
Adreno Cortical Carcinoma - Symptoms-Diagnosis-Treatment-Prognosis
Adrenocortical carcinoma is a rare but aggressive form of cancer that affects the outer cortex layer of the adrenals situated atop the ...
Drug Signifor for Cushing's Disease
European Union regulators approved Novartis drug Signifor as a treatment for Cushing's disease. The group said it was the first ...
Health In Focus News
Some Myths and Realities About Your Body
Be it from a word-of-mouth, or a newspaper article, unreliable and mis-interpreted facts always keep us in the dark. To shed some light, we've ...
Liver can be Damaged by Cinnamon
A compound called coumarin present in cinnamon is toxic to the liver even in small amounts, shows study. Cinnamon is a spice ...
Glutamate Responsible for Insomnia Associated With Restless Leg Syndrome: Hopkins Study
The neurotransmitter glutamate may play an important role in sleep loss in patients with restless leg syndrome, according to a study ...
Secondhand Smoke Destroys Good Cholesterol in Teen Girls
Teenage girls may be more vulnerable to the adverse effects of secondhand smoke when compared to boys of the same age, shows study. ...
Benefits of a Deep Breath
On an average, an individual breathes around 17,280-23,040 times a day, without giving it a second thought. When we breathe, we take ...
Fish Oil Supplements May Not Prevent Blindness: NIH Study
One of leading cause of blindness in developed world is age-related macular degeneration (AMD). AMD is a common eye condition among older adults ...
- Health News Index
 | Quiz on Cancer Looking for information on cancer? Go through medindia's Cancer quiz. 
|
- News Quick Links
 | News Central | | Health Watch | |
| Latest Health News | | Health In Focus | |
| News Category (500+) | | Breaking Health News | |
| Popular News | | Celebrating Life | |
| Health News and Press Release | | Medindia - Exclusive | |
| News Photo Gallery | | India Special | |
| News Video Gallery | | Lifestyle and Wellness | |
| News From Other Resources | |||
 |
Cancer
Complete Medindia Resources
|
| News Categories: |
| » | For Most Women Duchess Kate Is 'Style Icon' |
| » | Fruits and Veggies Could Be Kept Fresh for Longer Period With The Help of New Technology |
| » | Artists Complain That Ban on Wild Animals Brings Down Circus Industry |
| » | Researchers Explain Why Sports Fans Prefer to Stick to Their 'Lucky Products' |
| » | Google Glass's Offers Facial Recognition App Called MedRef |
| More Life Style News | |
|
Ask an Expert
